AVITA Medical, Inc.
RCEL
$4.62
$0.225.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.61M | 72.40M | 74.88M | 71.66M | 64.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.61M | 72.40M | 74.88M | 71.66M | 64.25M |
| Cost of Revenue | 12.79M | 11.77M | 11.77M | 10.41M | 9.09M |
| Gross Profit | 58.82M | 60.63M | 63.11M | 61.25M | 55.16M |
| SG&A Expenses | 80.51M | 82.72M | 88.17M | 91.01M | 91.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 114.15M | 114.49M | 121.62M | 122.88M | 120.84M |
| Operating Income | -42.54M | -42.09M | -46.74M | -51.21M | -56.59M |
| Income Before Tax | -48.58M | -48.51M | -51.57M | -57.01M | -61.79M |
| Income Tax Expenses | 10.00K | 46.00K | 3.00K | 32.00K | 54.00K |
| Earnings from Continuing Operations | -48.59 | -48.56 | -51.57 | -57.05 | -61.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.59M | -48.56M | -51.57M | -57.05M | -61.85M |
| EBIT | -42.54M | -42.09M | -46.74M | -51.21M | -56.59M |
| EBITDA | -40.24M | -40.03M | -44.95M | -49.77M | -55.47M |
| EPS Basic | -1.75 | -1.81 | -1.97 | -2.19 | -2.39 |
| Normalized Basic EPS | -1.04 | -1.09 | -1.19 | -1.33 | -1.46 |
| EPS Diluted | -1.75 | -1.81 | -1.97 | -2.19 | -2.39 |
| Normalized Diluted EPS | -1.04 | -1.09 | -1.19 | -1.33 | -1.46 |
| Average Basic Shares Outstanding | 111.40M | 107.16M | 104.75M | 104.14M | 103.53M |
| Average Diluted Shares Outstanding | 111.40M | 107.16M | 104.75M | 104.14M | 103.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |